Physician profile
Diba Daneshrad
NPI 1154575363
$2,312.78
in general payments reported to CMS, 2019-2025
9 companies · $141 in 2025
The $141 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $990 · 2021: $41.11 · 2022: $449 · 2023: $453 · 2024: $239 · 2025: $141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $833.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $833.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,352.88 | 2019-2023 | Confirm Rx, Cardiomems, Assurity |
| Fisher & Paykel Healthcare INC | $298.54 | 2024-2025 | Fisher & Paykel Healthcare |
| Intuitive Surgical, INC. | $188.92 | 2022-2023 | Da Vinci Surgical System |
| Abiomed | $187.17 | 2023-2024 | Impella |
| Edwards Lifesciences Corporation | $133.94 | 2019 | |
| Medtronic, INC. | $61.53 | 2022-2024 | Selectsecure, Capsurefix Novus Mri Surescan |
| Boston Scientific Corporation | $41.11 | 2021 | |
| Chiesi USA, INC. | $32.33 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $16.36 | 2023 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diba Daneshrad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.